Company Comparison
BioNTech vs 10x Genomics
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | BioNTech | 10x Genomics |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | Mainz that develops immunotherapies and vaccines, particularly | — |
| Founded | — | — |
| Status | Active | Active |
| Last Funding Stage | — | — |
| Total Funding | — | — |
| Valuation | — | — |
What They Build
BioNTech
BioNTech SE ( bee-ON-tek; or bye-ON-tek short for Biopharmaceutical New Technologies) is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases.
10x Genomics
10x Genomics, Inc. is an American biotechnology company that designs and manufactures sequencing technologies for use in scientific research, with a focus on product development for single-cell and spatial omics.
Key Investors
Shared Investors
3 firms have invested in both BioNTech and 10x Genomics.
Sector Overlap
Both BioNTech and 10x Genomics operate in Biotech.
Browse all Biotech companies →